Many patients report significant weight loss milestones coupled with improvements in their overall metabolic health after starting GLP-1 treatments
Stop at Satisfied, Not Full Learn the difference between "I could eat more" and "I'm satisfied." On GLP-1s, the jump from satisfied to uncomfortably full happens very quickly with just a few more bites
Some of these medications include: Ozempic (semaglutide) Mounjaro (tirzepatide) Saxenda (liraglutide) Wegovy (semaglutide) Zepbound (tirzepatide) Saxenda, Wegovy, and Zepbound are FDA-approved for weight management, while other GLP-1 medications are used primarily for Type 2 diabetes and are sometimes prescribed off-label for weight loss
Some clinicians manage discontinuation by gradually tapering the dose rather than stopping abruptly, and others transition patients to phentermine or other medications to blunt the regain
Mistake 8: Incorrect air bubble removal from vials Air bubbles in a syringe are not dangerous for subcutaneous injections
This can help: Support feelings of fullness after eating Reduce cravings and unnecessary snacking Maintain stable blood sugar levels Support sustained energy throughout the day Promote healthy metabolic function This natural approach supports long-term metabolic health without disrupting the bodys own regulatory systems
